Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14954464 | 0.92 | LPL (0.36) | LPLLIPG | |
| SCHEMBL2816050 | 0.86 | LPL (0.38) | LPLLIPG | |
| SCHEMBL4586623 | 0.85 | LPL (0.33) | LPLLIPGHIF1A | |
| SCHEMBL2226414 | 0.85 | LPL (0.31) | LPLLIPGHIF1A | |
| SCHEMBL12390693 | 0.83 | — | — | |
| SCHEMBL29851154 | 0.83 | ALDH1A1 (0.44) | LPLLIPGERBB2CYP1A2FYN | |
| SCHEMBL224510 | 0.83 | ALDH1A1 (0.44) | LPLLIPGERBB2CYP1A2FYN | |
| SCHEMBL14680420 | 0.82 | LPL (0.30) | LPLLIPG | |
| SCHEMBL24608926 | 0.80 | LPL (0.30) | LPLLIPG | |
| SCHEMBL2403716 | 0.80 | LPL (0.44) | LPLLIPGHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9988403-B2 | Compositions and methods for treating cancer with aberrant lipogenic signaling | THOMAS JEFFERSON UNIVERSITY (US) | 2018-06-05 | — | — | US | disclosed |
| US-9988403-B2 | Compositions and methods for treating cancer with aberrant lipogenic signaling | THOMAS JEFFERSON UNIVERSITY (US) | 2018-06-05 | — | — | US | disclosed |
| US-20180059566-A1 | UV-CURABLE LIQUID DEVELOPER, FIXING METHOD, IMAGE FORMING METHOD, AND UV-CURABLE COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
| US-20180059566-A1 | UV-CURABLE LIQUID DEVELOPER, FIXING METHOD, IMAGE FORMING METHOD, AND UV-CURABLE COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
| US-9812646-B2 | Organic compound and organic light-emitting device and display apparatus having the same | CANON KABUSHIKI KAISHA (JP) | 2017-11-07 | — | — | US | disclosed |
| US-9812646-B2 | Organic compound and organic light-emitting device and display apparatus having the same | CANON KABUSHIKI KAISHA (JP) | 2017-11-07 | — | — | US | disclosed |
| US-9750758-B2 | Compositions and methods for treating cancer with aberrant lipogenic signaling | THOMAS JEFFERSON UNIVERSITY (US) | 2017-09-05 | — | — | US | disclosed |
| US-9750758-B2 | Compositions and methods for treating cancer with aberrant lipogenic signaling | THOMAS JEFFERSON UNIVERSITY (US) | 2017-09-05 | — | — | US | disclosed |
| EP-2903958-B1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS HAVING THE SAME | CANON KK (JP) | 2017-08-30 | — | — | EP | disclosed |
| US-20170166593-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ABERRANT LIPOGENIC SIGNALING | THOMAS JEFFERSON UNIVERSITY (US) | 2017-06-15 | — | — | US | disclosed |
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080131731-A1 | CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-06-05 | — | — | US | disclosed |
| US-20080131731-A1 | CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-06-05 | — | — | US | disclosed |
| US-20080119671-A1 | PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2008-05-22 | — | — | US | disclosed |
| US-20080119671-A1 | PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2008-05-22 | — | — | US | disclosed |
| US-7365198-B2 | Silyl compound, light emitting material, and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2008-04-29 | — | — | US | disclosed |
| WO-2008015945-A1 | ORGANIC LUMINESCENT DEVICE AND BENZO[k]FLUORANTHENE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-02-07 | — | — | WO | disclosed |
| WO-2007123256-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2007-11-01 | — | — | WO | disclosed |
| US-20070205715-A1 | SILYL COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | AHR, CRY1, NR2E3 | LPL 2237/4885LIPG 3815/4885HIF1A 1246/4885 |
| US-20080131731-A1 | CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | OXA1L, CYP2C19, PPOX | LPL 2695/4885LIPG 3192/4885HIF1A 4090/4885 |
| US-20170166593-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ABERRANT LIPOGENIC SIGNALING | SREBF1, SREBF2, OSBP | LPL 56/4885LIPG 77/4885HIF1A 185/4885 |
| US-20080119671-A1 | PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | AHR, CYP1A1, ARNT | LPL 3508/4885LIPG 4480/4885HIF1A 2123/4885 |
| US-20070205715-A1 | SILYL COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LAS1L, CCNL2, EML4 | LPL 1558/4885LIPG 2825/4885HIF1A 3698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.